Literature DB >> 11593067

Optimizing treatment for chronic congestive heart failure in children.

R E Shaddy1.   

Abstract

Treatment strategies for chronic heart failure in children have generally been extrapolated from studies in adults with heart failure. This presentation reviews the existing knowledge and recommendations regarding the treatment of chronic heart failure in adults and the information that is available in children. Medications currently recommended for use in adults include diuretics, digoxin, angiotensin-converting enzyme inhibitors, and beta-blockers. These recommendations are based on results from large, randomized, multicenter trials. Anecdotal evidence suggests similar beneficial effects of these medications in children. The fact that the etiologies, pathophysiology, and physiologic consequences of heart failure in children often differ greatly from those in adults, however, justifies the development of prospective, randomized trials to evaluate these medications specifically in children. Findings from these types of studies will provide critical information for developing guidelines for the appropriate treatment of children with chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593067     DOI: 10.1097/00003246-200110001-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.

Authors:  Ozlem Elkiran; Ayse Sandikkaya; Gulendam Kocak; Cemsit Karakurt; Cagatay Taskapan; Saim Yologlu
Journal:  Pediatr Cardiol       Date:  2013-03-13       Impact factor: 1.655

2.  Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom.

Authors:  Hussain Mulla; Magdi Tofeig; Frances Bu'Lock; Nilesh Samani; Hitesh C Pandya
Journal:  Arch Dis Child       Date:  2007-03-15       Impact factor: 3.791

3.  Beta-adrenergic receptor antagonists and chronic heart failure in children.

Authors:  Sylvie Di Filippo
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.